GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:13 2026-01-23 am EST			5-day change	1st Jan Change
1,801.00 ^GBX	-0.19%		-0.85%	-1.29%

Jan. 23	The weekly recap: Things really heated up… for a chunk of ice
Jan. 23	GSK Says China Approves Trelegy Ellipta for Adults With Uncontrolled Asthma	MT

Transcript : GSK plc Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 07

Published on 01/14/2025 at 10:30 am EST

S&P Capital IQ

Presenter Speech
James Gordon (Analysts)

Good morning. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, it's my pleasure to introduce the GSK presentation. And you're going to

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about GSK plc

Jan. 23	The weekly recap: Things really heated up… for a chunk of ice
Jan. 23	GSK Says China Approves Trelegy Ellipta for Adults With Uncontrolled Asthma	MT
Jan. 23	GSK drug approved in China to treat uncontrolled asthma	AN
Jan. 23	GSK says Trelegy Ellipta approved in China for adults	RE
Jan. 22	GSK : JP Morgan reiterates its Sell rating	ZD
Jan. 22	Escalate, De-Escalate, Repeat
Jan. 22	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality	RE
Jan. 21	GSK : UBS remains Neutral	ZD
Jan. 21	RTW Biotech welcomes GSK deal to buy RAPT Therapeutics	AN
Jan. 20	PRESS DIGEST-Financial Times - Jan 21	RE
Jan. 20	S&P 500, Nasdaq slump to one-month lows as Greenland dispute triggers global selloff	RE
Jan. 20	Top Midday Gainers	MT
Jan. 20	European Stocks Close Lower in Tuesday Trading; UK Unemployment Rises to 5.1%	MT
Jan. 20	Global drugmakers rush to boost US presence as tariff threat looms	RE
Jan. 20	GSK : Receives a Sell rating from Barclays	ZD
Jan. 20	Sector Update: Health Care Stocks Decline Premarket Tuesday	MT
Jan. 20	Traders Digest Trump's Greenland Demands, US Equity Futures Down Pre-Bell	MT
Jan. 20	Greenland, Tariffs, and the Quiet Revolt of the Bond Market
Jan. 20	Top Premarket Gainers	MT
Jan. 20	RAPT Therapeutics Shares Jump Following Acquisition by GSK	DJ
Jan. 20	North American Morning Briefing : Futures Fall as Atlantic Tensions Rise	DJ
Jan. 20	Rapt Therapeutics Inc in case of termination, company to pay to GSK termination fee in cash equal to $78.4 million	RE
Jan. 20	GSK's Tesaro Licenses Alteogen Enzyme Technology	MT
Jan. 20	Deals of the day-Mergers and acquisitions	RE
Jan. 20	Wall Street skids to near three-week low as Greenland dispute triggers global sell-off	RE